Lv3
215 积分 2025-07-22 加入
Comparative efectiveness of mirikizumab and risankizumab in patients with ulcerative colitis: A propensity‑matched cohort study
10小时前
求助中
Comparative effectiveness of mirikizumab and risankizumab in patients with ulcerative colitis: A propensity-matched cohort study
2天前
已完结
Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension study
2个月前
已完结
IgG4-related disease: an update on pathophysiology and implications for clinical care
3个月前
已完结
Clinical Perspectives on IgG4-Related Disease and Its Classification
3个月前
已完结
Meta-Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel Disease
4个月前
已完结
Crohn’s disease and ulcerative colitis exhibit prediagnostic antibody signatures with shared and divergent changes towards disease onset
5个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
5个月前
已完结
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design
5个月前
已完结
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association study
5个月前
已完结
皖公网安备34019202002308
